| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/04/2004 | CN1136846C Formaldehyde injection for treating infective disease of animal |
| 02/04/2004 | CN1136843C Transdermal therapeutic system containing estradiol |
| 02/04/2004 | CN1136842C Drug composition with controlled drug release rate |
| 02/04/2004 | CN1136841C Group gel type liposome and its composition and application |
| 02/04/2004 | CN1136840C Non-aqueous controlled release pest and air care gel composition |
| 02/04/2004 | CN1136839C Quick-acting ointment for treating dermatitis and eczema |
| 02/04/2004 | CN1136838C Solid, quick dissolving cetirizine fomulation |
| 02/04/2004 | CN1136837C Taste making liquids |
| 02/03/2004 | US6687546 Ambulatory medical apparatus and method using a robust communication protocol |
| 02/03/2004 | US6686442 Peptide nucleic acid for use in veterinary medicine |
| 02/03/2004 | US6686382 N-(isoxazolyl)thienylsulfonamides, n-(isoxazolyl)furylsulfonamides, n-(isoxazolyl)pyrrolylsulfonamides and n-(isoxazolyl)phenylsulfonamides; inhibit endothelin |
| 02/03/2004 | US6686346 Formulation |
| 02/03/2004 | US6686342 Bicompatible poly-β-1→4-N-acetylglucosamine |
| 02/03/2004 | US6686330 Low-foaming; good biodegradability; can be used in polymer, antifoaming, biocidal, coating, fertilizer, pharmaceutical, and drilling fluid compositions. |
| 02/03/2004 | US6686326 Azeotrope-like compositions or pentafluorobutane |
| 02/03/2004 | US6686177 Delayed onset of action |
| 02/03/2004 | US6685971 Oil homogenized with sterols; protective coating for stomach |
| 02/03/2004 | US6685969 Treatment for ectoparasites |
| 02/03/2004 | US6685967 Spray dried powder |
| 02/03/2004 | US6685966 Hydrophobic material dispersed in addition polymer encapsulated in external coating of an oxide and/or hydroxide of aluminum, silicon, zirconium and/or a transition metal; intermediate coating of an alkaline earth metal hydroxide |
| 02/03/2004 | US6685965 Process for stabilizing levogyre ascorbic acid (laa), a stable aqueous laa composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment |
| 02/03/2004 | US6685964 Coated crystals |
| 02/03/2004 | US6685963 Diphasic injection composition containing dispersed and continuous phases useful for reparative and plastic surgery |
| 02/03/2004 | US6685962 Enclosed in insoluble membranes |
| 02/03/2004 | US6685961 Colored gelatin-based formulations and method |
| 02/03/2004 | US6685960 Solid lipidic nanospheres suitable to a fast internalization into cells |
| 02/03/2004 | US6685959 Pharmaceutical compositions comprising 2-isoxazoles-8-aminotetralin derivatives |
| 02/03/2004 | US6685958 E.g., 7-(3-amino-2,3,4,5,6,7-hexahydro-1h-azepin-1-yl)-8-chloro-1-cyclopropyl-6 -fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid; treatment of ocular and periocular infections. |
| 02/03/2004 | US6685957 Preparation of fibrous polymer implant containing bioactive agents using wet spinning technique |
| 02/03/2004 | US6685956 Variations blends of fibers; sustained release; drug delivery |
| 02/03/2004 | US6685954 For application to skin |
| 02/03/2004 | US6685951 Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine |
| 02/03/2004 | US6685937 Administering an effective amount of at least one lytic enzyme produced by a bacteria infected with a bacteriophage specific for said bacteria to the site of the infection |
| 02/03/2004 | US6685930 When binding molecules reach maximum concentration in tumor a liposome conjugated with antibodies is administered to clear them from the blood; single chain vh-vl binding molecules conjugated with peptide linker, solid tissue antigen binder |
| 02/03/2004 | US6685928 Therapeutic compositions and methods |
| 02/03/2004 | US6685917 Treatment of mucositis |
| 02/03/2004 | US6685697 Controlled release system for delivering therapeutic agents into the inner ear |
| 02/03/2004 | US6685675 Medical device adhering to the skin |
| 02/03/2004 | US6685626 Compositions, devices, methods, and kits for induction of adhesions |
| 02/03/2004 | US6685618 Method for delivering radiation to an intraluminal site in the body |
| 02/03/2004 | US6685452 Implantable drug delivery pump with desiccant humidity protection |
| 02/03/2004 | US6685042 Feeder bottles |
| 02/03/2004 | CA2300806C Dexamethasone gel |
| 02/03/2004 | CA2248167C Patch containing isosorbide dinitrate |
| 02/03/2004 | CA2182244C Camptothecin derivatives |
| 02/03/2004 | CA2113225C Tablet dipping systems for apparatus for gelatin coating tablets |
| 02/03/2004 | CA2100655C Oxypurine nucleosides and their congeners, and acyl derivatives thereof, for improvement of hematopoiesis |
| 02/03/2004 | CA2099076C Rotomelt granulation |
| 02/03/2004 | CA2079444C Binding of recognizing substances to liposomes |
| 01/31/2004 | CA2436469A1 Composition for heart disease, method to prepare same and uses thereof |
| 01/31/2004 | CA2425568A1 Herbal pharmaceutical composition for treatment of hiv/aids patients |
| 01/29/2004 | WO2004009666A2 Dendrimers as molecular translocators |
| 01/29/2004 | WO2004009665A2 Dendrimers as molecular translocators |
| 01/29/2004 | WO2004009664A2 Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from |
| 01/29/2004 | WO2004009445A2 Packaging and dispensing of rapid dissolve dosage form |
| 01/29/2004 | WO2004009319A1 Method and apparatus for making miniature tablets |
| 01/29/2004 | WO2004009172A1 Microneedle devices and microneedle delivery apparatus |
| 01/29/2004 | WO2004009162A1 Infusion pump, method, control program and semiconductor means for the dosed administration of a medicinal liquid |
| 01/29/2004 | WO2004009160A1 An infusion pump system, an infusion pump unit and an infusion pump |
| 01/29/2004 | WO2004009126A1 Targeted agents for nerve regeneration |
| 01/29/2004 | WO2004009123A2 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 01/29/2004 | WO2004009122A1 Mucoadhesive composition and formulation for solubilization of insoluble drugs and preparation method thereof |
| 01/29/2004 | WO2004009121A1 Pharmaceutical compositions comprising hepatitis c viral protease inhibitors |
| 01/29/2004 | WO2004009120A1 Hybrid of itraconazole, cyclosporine or carvedilol with a layered silicate and a process for preparing the same |
| 01/29/2004 | WO2004009111A1 Corneal epithelium injury-healing accelerator |
| 01/29/2004 | WO2004009108A1 Antipyrotic and method of manufacturing the same |
| 01/29/2004 | WO2004009096A1 Use of compositions comprising salicylic acid and glycyrrhetinic acid for the treatment of acne |
| 01/29/2004 | WO2004009095A1 Use of compositions comprising benzoyl peroxide and glycyrrhetinic acid for the treatment of acne |
| 01/29/2004 | WO2004009089A1 Enhancing the effect of radioimmunotherapy in the treatment of tumors |
| 01/29/2004 | WO2004009088A1 4-(4-methylpiperazin-1-ylmethyl)-n-[4-pyridin-3-yl)pyrimidin-2-ylamino)phenyl]-benzamide for treating anaplastic thyroid cancer |
| 01/29/2004 | WO2004009085A2 Taste masked sumatriptan tablets and processes for their preparation |
| 01/29/2004 | WO2004009077A1 TASTE-MASKED LIQUID PHARMACEUTICAL COMPOSITION COMPRISING A COMPLEX OF A HISTAMINE h2-RECEPTOR ANTAGONIST AND ALGINATE |
| 01/29/2004 | WO2004009076A1 Paclitaxel composition for the intravesical treatment of bladder tumor and preparation method thereof |
| 01/29/2004 | WO2004009075A1 Composition for solubilization of paclitaxel and preparation method thereof |
| 01/29/2004 | WO2004009073A1 P-glycoprotein inhibitor comprising octilonium bromide as an effective ingredient |
| 01/29/2004 | WO2004009063A1 TOPICAL ANTIINFLAMMATORY PREPARATIONS OF η-TERPINENE |
| 01/29/2004 | WO2004009061A2 Bioavailability/bioefficacy enhaning activity of cuminum cyminum and extracts and fractions thereof |
| 01/29/2004 | WO2004009060A1 Nanoparticles for the administration of active ingredients, method of producing said particles and composition containing same |
| 01/29/2004 | WO2004009059A1 Taste masked oral composition of telithromycin |
| 01/29/2004 | WO2004009058A1 Process for the preparation of pharmaceutical microcapsules with enhanced taste-masking and high dissolution rate |
| 01/29/2004 | WO2004009057A1 Process for the preparation of crystalline nano-particle dispersions |
| 01/29/2004 | WO2004009056A1 Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent |
| 01/29/2004 | WO2004009053A2 Oral delivery system containing a gel matrix and liposomes |
| 01/29/2004 | WO2004009019A2 Method for incorporating cationic molecules into a substrate for increasing dispersibility of cationic molecules |
| 01/29/2004 | WO2004008871A2 Device for orally absorbing a substance, use thereof as confectionery, tonic food, (phyto)therapeutic product and dental hygiene product and method for making such a device |
| 01/29/2004 | WO2003097021A3 Use of transdermal topical systems for the prevention and treatment of primary dysmenorrhea |
| 01/29/2004 | WO2003094827A3 Dispersions of lipids for use as therapeutic and cosmetic agents and intracellular delivery vehicles |
| 01/29/2004 | WO2003086362A3 Method of stabilizing bupropion hydrochloride tablets |
| 01/29/2004 | WO2003065980A3 Methods and formulations for eradicating or alleviating staphylococcal nasal colonization using lysostaphin |
| 01/29/2004 | WO2003057153A3 Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol |
| 01/29/2004 | WO2003041638A3 Suppository base |
| 01/29/2004 | WO2003037406A3 Transdermal transport device with an electrolytic actuator |
| 01/29/2004 | WO2003032924A3 Novel tibolone formulations |
| 01/29/2004 | WO2003030818A3 Active agents using liposome beads |
| 01/29/2004 | WO2003028654A3 Storage-stable human fibrinogen solutions |
| 01/29/2004 | WO2003020324A3 Methods for sterilizing preparations of digestive enzymes |
| 01/29/2004 | WO2003017947A3 Spontaneous emulsions containing cyclosporine |
| 01/29/2004 | WO2002064014A9 Endomural therapy |
| 01/29/2004 | US20040019345 Which is positioned within capsule |
| 01/29/2004 | US20040019335 Labial product system to maintain a treatment agent |